How many investments has Recode Ventures made?

Recode Ventures has 13 tracked investments.

What stage does Recode Ventures invest at?

Recode Ventures invests at the Seed, Series A stages.

Where is Recode Ventures located?

Recode Ventures is headquartered in San Francisco, US.

Who does Recode Ventures co-invest with?

Recode Ventures most often shares deals with Y Combinator, Atomico, DCVC (Data Collective), among 42 tracked co-investors.

Recode Ventures

Venture capital

San Francisco · Seed–Series A · 8 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Recode Ventures

Each arrow is one introduction. Sign up to fill in the first one.

2,395 people can intro you to Armen

Ask Hanson S. Gifford, III to introduce you to Armen A. Vidian

You →Hanson · together at Evalve, Inc. [a wholly owned subsidiary of Abbott Vascular, Inc.] →Armen

1,036 people can intro you to Vishal

Ask Jamie Chen to introduce you to Vishal Gulati

You →Jamie · together at Healthily →Vishal

445 people can intro you to Jeff

Ask Sam Okafor to introduce you to Jeff Berkowitz

You →Sam · together at Physicians Interactive →Jeff

Tim Garnett187 people can intro you
Lloyd Appel77 people can intro you
Baroness Nicola Blackwood2 people can intro you

Your email: who you already know at Recode Ventures, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Recode Ventures team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

✨ Fox Verdict

Investment thesis

Recode Ventures believes healthcare is at an inflection point where exponential and deep technologies are converging to enable profound breakthroughs. The firm backs tech-native seed and Series A founders who understand rapid technological change and are positioned to transform an industry still relying on outdated playbooks. Drawing on decades of life science and deep tech venture-stage experience, the team — comprised of founders, doctors, engineers, scientists and entrepreneurs — has participated firsthand in transformative moments spanning early ideation, FDA approvals, IPOs and M&A. This hands-on operating and investing background informs their worldview and helps them nurture companies through the complex and evolving healthcare landscape.

Invests inAI & Machine Learning Biotech Deep Tech Digital Health Healthtech Medical Devices San Francisco United Kingdom United States

Source: firm website, verified Sep 27, 2026.

Leave your own feedback

Stage

Seed–Series A

San Francisco, CA, US

Instruments

Equity

Tracked investments

Team · 8 people

from the firm's website & public directories

Vishal Gulati· Founder & Managing Partner· Londonin 𝕏

A founding partner of Recode Ventures noted by portfolio founders for deep expertise in genetic medicines and healthtech, an extensive network, and hands-on board-level guidance through regulatory and commercial challenges.

Armen A. Vidian· Founder and Managing Partner· San Francisco, Californiain 𝕏

A founding partner of Recode Ventures recognized by founders for his understanding of deep tech execution and business drivers, and for balancing founder empathy with direct communication as a board member.

Baroness Nicola Blackwood· Equity Partnerin

Leader in science and entrepreneurship serving as Chair of Genomics England and Oxford University Innovation, and as a board member of BioNTech. Former UK Minister for Innovation in the Department for Health and Social Care, overseeing life sciences, NHS data, and digital transformation. Member of the House of Lords and the Royal Society Science Policy Expert Advisory Committee.

Jeff Berkowitz· Equity Partner· New York City Metropolitan Areain

Healthcare executive with extensive experience across the global healthcare supply chain, including roles as Executive Vice President at UnitedHealth Group/Optum, President of Pharma and Global Market Access at Walgreens Boots Alliance, and senior vice president of global market access at Merck. Currently CEO of Real Endpoints, a firm focused on pharmaceutical access and market dynamics.

Sir Bruce Keogh· Equity Partner

Distinguished cardiac surgeon and former Medical Director of the NHS and Director General of the Department of Health (2007-2018), where he led clinical policy and strategy. He was knighted in 2003 for services to medicine and has been ranked as the most influential clinician in the NHS. Currently chairs the Birmingham Women's and Children's NHS Foundation Trust.

Tim Garnett· Equity Partner· Chicago, Illinois, United Statesin

Veteran of the pharmaceutical industry with over 20 years at Eli Lilly, including service as Chief Medical Officer from 2008 to 2021. He led development of therapeutics in women's health, endocrinology, and neuroscience through regulatory approval and global launch. Holds medical qualifications and fellowships in pharmaceutical medicine and obstetrics/gynaecology.

Julie Norledge· Executive Assistant

Executive Assistant and Office Manager at Recode since 2022 with over two decades of experience supporting founders and entrepreneurs in diverse industries including film and television production, legal, and luxury retail. She provides administrative and back-office organization.

Lloyd Appel· CFO· United Statesin

CFO with over 30 years of financial management experience at alternative asset firms including hedge funds and venture capital funds. A CPA and CFA who began his career at BDO.

lloyd@differential.vc

What they invest in

from 9 of 13 portfolio companies

AI & Machine Learning ×7Biotech ×6Healthtech ×5Deep Tech ×3Digital Health ×3Medical Devices ×3Advanced Manufacturing ×1Enterprise Software ×1

HQs:United States×4United Kingdom×1

Who they back

founder profiles across 6 portfolio companies

30%

repeat founders

of 10 founders with career history

What their founders studiedfrom 11 founders with field-of-study data

Engineering ×7Life Sciences ×4Business & Management ×2Computer Science ×2

Where their founders worked beforefrom 10 founders with career history

Imperial College London ×3University of Oxford ×2

Accelerator rootsportfolio companies that came through a program

Y Combinator ×3

Investments · 13 tracked

founders shown can be your intro path

By year:2023 · 1 2017 · 1 2014 · 13 dated

3Scan3scan.comNov 2014

San Francisco, US

Todd Huffman(Founder)Megan Klimen(Founder)

BoardJoshua Wolfe(Director)Matt Ocko(Director)in Adam Goulburn(Director)inAdam Goulborn(Director)

Co-investorsComet Labs Dolby Family Ventures DCVC (Data Collective)Dimension Capital Lux Capital OS Fund

Caption Carecaption-care.com

Caption Care delivers cardiac ultrasounds (echocardiograms) performed in clinics or patients' homes using AI-guided imaging and interpretation technology, enabling earlier detection of heart disease.

AI & Machine LearningDigital HealthMedical Devices

Partner Armen A. Vidian· solo GP

Coincidence Labscoincidencelabs.com in

Coincidence Labs builds an AI orchestration layer that connects existing systems and digitizes paper records into a unified data layer, so AI agents can execute time-sensitive tasks like regulatory documentation with human review when needed.

Advanced ManufacturingAI & Machine LearningEnterprise Software

Partner Armen A. Vidian· solo GP

LabGeniuslabgeni.us in 𝕏Oct 2017

LabGenius develops EVA, an automated discovery engine for identifying and co-optimizing complex therapeutic antibodies such as multispecifics across multiple properties.

AI & Machine LearningBiotechDeep TechLondon

Harrison Rickerby(Executive Officer, Director)

BoardJames Field(Founder)in

Partner Armen A. Vidian· solo GP

Co-investorsAcequia Capital (AceCap)Air Street Capital Atomico Backed Beast Ventures Champion Hill Ventures +10 more

Nanograbnanograb.com in 𝕏

Nanograb develops gene therapy delivery systems using artificial intelligence to identify peptide-nanoparticle combinations that transport genetic medicines to targeted cells and tissues.

BiotechHealthtechSan Francisco, US

Debesh Mandal(Founder)in Christopher Lau(Founder)in Shanil Panara(Founder)in

Partner Armen A. Vidian· solo GP

Co-investorsSterling Road Y Combinator Agrolimen Ventures BlueYard Capital Sandhill (ex Stonks)

PatientGeniepatientgenie.ai

Partner Armen A. Vidian· solo GP

Persona-Dxpersona-dx.com

Partner Armen A. Vidian· solo GP

Probably Geneticprobablygenetic.com in 𝕏

Probably Genetic operates a platform for diagnosing genetic diseases, providing comprehensive genetic data and testing to patients and healthcare providers.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesSan Francisco, US

Lukas Lange(Founder)inHarley Katz(Founder)

Partner Armen A. Vidian· solo GP

Co-investorsAsymmetric Capital Partners Calm/Storm VC Manta Ray Ventures Oxonian Ventures Think+ Ventures Management, Llc Threshold Ventures +6 more

Propriopropriovision.com in 𝕏

Proprio develops Paradigm, an implant-agnostic surgical platform that provides intraoperative guidance and structured surgical data without requiring 3D imaging or mobile CT.

AI & Machine LearningHealthtechMedical DevicesSeattle, US

Gabriel Jones(Co-founder & CEO)in Samuel Browd(Co-founder)inJoshua Smith(Co-founder)inJames Youngquist(Co-founder)in

Partner Armen A. Vidian· solo GP

Co-investorsBold Capital Partners Cota Capital DCVC (Data Collective)Bird B. AG HTC Presence Capital +4 more

Sensible Biotechnologiessensible.bio in 𝕏Feb 2023

Sensible Biotechnologies develops a cell-based mRNA design and manufacturing platform that produces pure, low immunogenicity mRNA therapeutics for drug development.

AI & Machine LearningBiotechDeep TechHealthtechOxford, GB

Miroslav Gasparek(Founder)in Marian Kupculak(Founder)in

BoardVishal Gulati(Director)Joel Schoppig(Director)

Partner Armen A. Vidian· solo GP

Co-investorsCivilization Ventures Management, Llc KAYA Traun Ventures Y Combinator ZAKA VC Amino Collective +11 more

Verisianverisian.com in 𝕏

Verisian builds software for clinical research and public health authorities to analyze and monitor clinical trial data in real-time, improving decision-making and trial safety.

BiotechDigital HealthHealthtechSaaS

Henning Kuich(Founder)Tomas Sabat(Founder)

BoardSunil Gupta(Strategic Advisor)

Partner Armen A. Vidian· solo GP

Co-investorsCambridge Angels group SuperSeed 6 Dimensions Capital ManchesterStory Group, LLC

Waypoint Biowaypointbio.com in 𝕏

Waypoint Bio uses artificial intelligence, computer vision, and pooled screening to conduct deep phenotyping across thousands of cell therapy designs, enabling the discovery and optimization of superior cell therapy candidates for development.

AI & Machine LearningBiotechDeep Tech

Xinchen Wang, Ph.D.(Co-founder & CEO)David Phizicky, Ph.D.(Co-founder & CSO)Xinchen Wang(Founder)in

Partner Armen A. Vidian· solo GP

Co-investorsAmplify Partners Fifty Years Hummingbird Ventures MBX Capital Mitsui Global Investment Village Global +4 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Clue

Portfolio news

latest coverage across their companies

Waypoint Bio Raises $20M in Series A Funding

Waypoint Bio · finsmes.com · Jun 2, 2026

Probably Genetic Secures $10.7M Series | Signalbase

Probably Genetic · trysignalbase.com · Mar 24, 2026

Sartorius Stedim Biotech and Sensible Biotechnologies Partner to Scale Up Sensible’s Unique Cell-Based mRNA Design and Manufacturing Platform

Sensible Biotechnologies · finance.yahoo.com · Jul 9, 2025

Frequently asked questions

How many investments has Recode Ventures made?: Recode Ventures has 13 tracked investments.
What stage does Recode Ventures invest at?: Recode Ventures invests at the Seed, Series A stages.
What sectors does Recode Ventures focus on?: Recode Ventures focuses on AI & Machine Learning, Biotech, Deep Tech, Digital Health, Healthtech, Medical Devices.
Where is Recode Ventures located?: Recode Ventures is headquartered in San Francisco, US.
Who does Recode Ventures co-invest with?: Recode Ventures most often shares deals with Y Combinator, Atomico, DCVC (Data Collective), among 42 tracked co-investors.

Media · Podcasts & interviews

featuring the team

Keynote: Peter Hebert, Lux Capital, and Armen Vidian, Recode Ventures | LSI USA '26

LSI - Life Science Intelligence™ · Armen Vidian

Images

Co-investors · 11

Lux Capital

Lux Capital is a venture capital firm that backs founders building transformative deep technologies, having been among the first investors in category-defining companies across AI, robotics, biotech, defense, and infrastructure.

Both backed · 3

3Scan LabGenius Waypoint Bio

$100K – $100M

DCVC (Data Collective)

DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.

Both backed · 2

3Scan Proprio

$5M – $25M

Bold Capital Partners

BOLD Capital Partners is a venture capital firm that backs entrepreneurs and companies pursuing transformative science and technology aimed at disrupting and democratizing large markets and addressing major human challenges.

Both backed · 1

Proprio

SuperSeed

SuperSeed is a seed-stage venture capital firm that invests in software startups, typically supporting companies through their initial growth phase toward £1m in revenue. The firm provides capital and operational guidance to early-stage founders.

Both backed · 1

Verisian

$127K – $635K

Bling Capital

Bling Capital is a seed-stage venture firm that helps entrepreneurs find and scale product-market fit, backed by a Product Council of 100+ product leaders.

$1M – $5M

UpHonest Capital

UpHonest Capital is a Silicon Valley-based investment firm founded in 2017 that supports cross-border entrepreneurship and investment between China and the United States, and runs media, scout, and incubation programs.

$50K – $1M

IA Ventures

IA Ventures is a venture capital firm that invests in early-stage software and frontier technology companies.

$1M – $3M

Passion Capital

Passion Capital is an early-stage venture capital firm that backs European founders building technology companies, with a focus on AI, FinTech and Risk.

Artis Ventures

ARTIS Ventures is a venture capital firm investing in breakthrough companies at the convergence of technology and biology, with a focus on healthcare and life sciences ('TechBio'). It backs founders across biotech, therapeutics, digital health, and frontier technologies.

$50K – $25M

Molten Ventures

Molten Ventures invests in European technology companies across sectors including fintech, AI, climate and quantum, with a portfolio spanning over 100 companies.

$2.5M – $63M

Foresite Capital

Foresite Capital is a healthcare-focused investment firm backing companies at the intersection of technology and biotechnology to personalize healthcare and accelerate medical innovation.

Firms observed investing alongside Recode Ventures, from public investor directories. Shared companies are the overlap with Recode Ventures's recorded portfolio.

Similar investors

Amadeus Capital Partners

Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.

$50K – $12.7M

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

Capricorn Venture Partners

Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.

$270K – $10.8M

DCVC (Data Collective)

DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.

$5M – $25M

Future Positive Capital

Future Positive Capital is a venture firm backing entrepreneurs building companies that address large-scale global challenges across health, sustainability and technology.